Imatinib Mesylate and Combination Chemotherapy With or Without a Donor Stem Cell Transplant in Treating Patients With Newly Diagnosed Acute Lymphoblastic Leukemia

NCT00618501 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

50

Enrollment

OTHER

Sponsor class

Conditions

Leukemia

Interventions

DRUG: cytarabine
DRUG: daunorubicin hydrochloride
DRUG: etoposide
DRUG: imatinib mesylate
DRUG: leucovorin calcium
DRUG: methotrexate
DRUG: prednisolone
DRUG: therapeutic hydrocortisone
DRUG: vincristine sulfate
PROCEDURE: allogeneic hematopoietic stem cell transplantation

Sponsor

Asan Medical Center